Epilepsja i neuralgia nerwu trójdzielnego jako zespoły nadwrażliwości nerwowej: wspólne mechanizmy i możliwości leczenia na podstawie badań nad drażnieniami nerwu trójdzielnego u koni
PubMed➕ 22.11.2026J Comp Pathol
Epilepsy and trigeminal neuralgia as regional hyperexcitability syndromes: converging mechanisms and translational insights from equine trigeminal-mediated headshaking
W skrócie
Epilepsja i neuralgia nerwu trójdzielnego to choroby, które wydają się zupełnie różne, ale mają wspólny problem: nerwy w mózgu i twarzy są zbyt pobudliwe i źle się kontrolują. Badania pokazują, że wiele leków działa na obie choroby, a konie naturalnie chorują na podobny problem, co pomaga lekarzom lepiej zrozumieć, jak leczyć pacjentów. Artykuł wyjaśnia, że zarówno epilepsja, jak i ból nerwu trójdzielnego należy traktować jako zaburzenia nadmiernego pobudzenia nerwów, które można leczyć nowoczesnymi metodami działającymi na różne poziomy tego problemu.
Oryginalny abstract (angielski)
Epilepsy and trigeminal neuralgia (TN) are treated traditionally as unrelated disorders, one defined by recurrent seizures, the other by paroxysmal facial pain. Yet both share a core pathophysiological feature: regional loss of neuronal excitability control, driven by gain-of-function in voltage-gated sodium channels (Nav1.3, Nav1.6, Nav1.7); failure of gamma-aminobutyric acid (GABA)ergic inhibition, disruption of the blood-brain and blood-nerve barriers with transforming growth factor-β-mediated neuroinflammation; and emergent network hypersynchrony. Pharmacologically, carbamazepine, oxcarbazepine, gabapentin and baclofen act across both conditions; neuromodulation with repetitive transcranial magnetic stimulation reduces excitability in epileptic foci and trigeminocervical circuits alike. Equine trigeminal-mediated headshaking (TMHS) presents as a spontaneous large-animal phenotype that matches this framework; affected horses show infraorbital trigeminal activation thresholds below 5 mA without structural lesion, seasonal and exercise-dependent fluctuation in clinical signs and partial response to percutaneous electrical nerve stimulation and magnesium supplementation. This narrative review synthesizes mechanistic evidence across epilepsy, TN and TMHS and maps their phenotypic overlap with related primary headache syndromes. It is proposed that all three conditions are best conceptualized as regional hyperexcitability syndromes differing primarily by network location and access to peripheral modulators such as posture, cervical biomechanics and autonomic tone. Recognizing this convergence supports cross-species therapeutic strategies targeting ion channels, inflammatory signalling, barrier stability and network-level neuromodulation, and identifies TMHS as a clinically tractable, welfare-relevant translational model.